For vernal keratoconjunctivitis, when should the patient be re-evaluated to ensure resolution?

Prepare for the NBEO Part III Test with comprehensive questions on Patient Encounters and Performance Skills. Answer multiple choice and scenario-based questions with explanations. Ensure success on your optometry exam!

Multiple Choice

For vernal keratoconjunctivitis, when should the patient be re-evaluated to ensure resolution?

Explanation:
After starting treatment for vernal keratoconjunctivitis, you want to confirm that the inflammatory process is responding and that symptoms are improving. Improvement in VKC with appropriate therapy is typically evident within a couple of weeks, so re-evaluating in about two to three weeks gives a clear window to assess resolution and adjust therapy if inflammation persists. Waiting much longer risks missing ongoing disease or developing complications, while rechecking too soon (like after a week) may not capture meaningful improvement. If steroids or other potent medications are used, closer monitoring for side effects is needed, but for confirming resolution, a two to three week follow-up is appropriate.

After starting treatment for vernal keratoconjunctivitis, you want to confirm that the inflammatory process is responding and that symptoms are improving. Improvement in VKC with appropriate therapy is typically evident within a couple of weeks, so re-evaluating in about two to three weeks gives a clear window to assess resolution and adjust therapy if inflammation persists. Waiting much longer risks missing ongoing disease or developing complications, while rechecking too soon (like after a week) may not capture meaningful improvement. If steroids or other potent medications are used, closer monitoring for side effects is needed, but for confirming resolution, a two to three week follow-up is appropriate.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy